CRISPR Therapeutics AG (CRSP) EBT Margin (2016 - 2026)
CRISPR Therapeutics AG's EBT Margin came in at -885.91% for Q2 2026, up 22349.18 percentage points from -23235.09% a year earlier and up 7488.03 percentage points from the prior quarter.
CRISPR Therapeutics AG (CRSP) EBT Margin (2016 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CRISPR Therapeutics AG reported EBT Margin of -3346.08%, down 2127.10 percentage points year-over-year; for FY2025, it was -16466.24%, down 15494.31 percentage points from FY2024.
- EBT Margin carries a five-year change of +31942.11 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -971.93% in FY2024 (-931.32 pp), -40.60% in FY2023 (+54258.23 pp), -54298.83% in FY2022 (-54340.31 pp) and 41.48% in FY2021 (+48449.83 pp).
- The Q2 2026 figure represents the highest quarterly EBT Margin since Q4 2024.
- Year-over-year, EBT Margin increased in five of the last seven quarters, with an average year-over-year change of +3581.05 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q4 2023 (a gain of 2000894.52 percentage points), and the weakest in Q4 2022 (a drop of 1999737.50 percentage points).
- Business Quant data shows CRSP's EBT Margin at -8373.94% (Q1 2026), -15046.18% (Q4 2025) and -11903.49% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | -885.91% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -885.91% |
| Mar 31, 2026 | -8,373.94% |
| Dec 31, 2025 | -15,046.18% |
| Sep 30, 2025 | -11,903.49% |
| Jun 30, 2025 | -23,235.09% |
| Mar 31, 2025 | -15,593.87% |
| Dec 31, 2024 | -102.58% |
| Sep 30, 2024 | -14,130.56% |
| Jun 30, 2024 | -24,201.35% |
| Mar 31, 2024 | -22,989.48% |
| Dec 31, 2023 | 44.52% |
| Jun 30, 2023 | -109.74% |
| Mar 31, 2023 | -51.75% |
| Dec 31, 2022 | -2,000,850.00% |
| Sep 30, 2022 | -186,302.13% |
| Jun 30, 2022 | -113,744.30% |
| Mar 31, 2022 | -18,681.81% |
| Dec 31, 2021 | -1,112.50% |
| Sep 30, 2021 | -15,503.40% |
| Jun 30, 2021 | 84.75% |
CRISPR Therapeutics AG EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();